Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma

• Egile Nagusiak: Fenglin Li (Egilea), Yi Lai (Egilea), Jiayi Ye (Egilea), Madiha Saeed (Egilea), Yijing Dang (Egilea), Zhifeng Zou (Egilea), Fangmin Chen (Egilea), Wen Zhang (Egilea), Zhiai Xu (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2022-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Glioblastoma (GBM) therapy is severely impaired by the blood-brain barrier (BBB) and invasive tumor growth in the central nervous system. To improve GBM therapy, we herein presented a dual-targeting nanotheranostic for second near-infrared (NIR-II) fluorescence imaging-guided photo-immunotherapy. Fi...